Objective-To determine the prognosis of supravalve aortic stenosis into early adult life and the factors affecting this prognosis. Design-81 patients with supravalve aortic stenosis were followed for a median duration of 8. 
sporadic supravalve aortic stenosis, and five (6-2%) other syndromes. Nineteen patients had additional levels of left ventricular outflow tract obstruction. Results-47 patients (58%) underwent operation; 20% within a year of presentation. Multivariable analysis predicted that 88% of patients would undergo intervention within 30 years of follow up. The chance of intervention was increased by more severe aortic stenosis at presentation and the presence of multilevel obstruction in patients with sporadic supravalve aortic stenosis. Three deaths occurred before operation and 13 within a month of operation. Ten (62.5%) of the postoperative deaths were in patients with multilevel obstruction. Predicted survival 30 years after presentation was 66%. Risk factors for survival were age and severity of aortic stenosis at presentation. Multilevel obstruction did not emerge as a significant risk factor for death because of the high association with the severity of stenosis at presentation. 74% of survivors had mild or insignificant stenosis at follow up. Conclusions-Long-term survival is related to age and the severity of aortic stenosis at presentation. Most 4 Progression with time has been demonstrated,256 but these reports contain relatively small numbers of patients. The aims of this study were to determine the prognosis of patients with supravalve aortic stenosis from presentation into early adult life and define the factors influencing that prognosis.
Patients and methods
Eighty one patients (52 (64%) were male) with supravalve aortic stenosis who presented to the Royal Liverpool Children's Hospital between 1 January 1960 and 31 December 1992 were included. The severity of stenosis at presentation was determined from clinical data, together with echo/Doppler or cardiac catheterisation assessment if performed within a year of presentation. The criteria for assessing the severity of stenosis were the same as those used in a previous study.7 Patients Values in parentheses are percentages. *Noonans (n = 2); Shones (n = 2); rubella (n = 1). 
Results
The median age at presentation was 13-8 months with a range of 3 days to 12 years. ). There was no difference in the distribution of severity of aortic stenosis at presentation related to the various associated conditions (P = 0-12). However, patients with more severe stenosis at presentation had an increased tendency (P < 0-001) to have multilevel obstruction (table 2) . Other cardiovascular lesions were found in 40 patients (49A4%) (table 3 ).
There was no difference in the incidence of other cardiac lesions in patients with supravalve aortic stenosis alone (n = 29; 46 8%) and those with multilevel obstruction (n = 11; 58%). With one exception, aortic arch obstruction occurred only in patients with multilevel obstruction. Aortic regurgitation was found at presentation in three patients (3 7% ) who all had additional aortic valve stenosis.
The median duration of follow up in survivors was 8-3 (range 1-29) years. Nine patients were lost to follow up after a median duration of 11 (range 4-1-18-4) years. Aortic regurgitation was found in four patients with additional aortic valve stenosis at follow up. Infective endocarditis was not encountered.
INTERVENTION
Forty seven patients (58%) underwent operation for supravalve aortic stenosis (table 4). The median age at first operation was 4 9 (range 0-1-20-9) years and there was no difference in relation to the various associated conditions. All patients underwent cardiac catheterisation before surgery and the peak systolic gradient across the left ventricular outflow tract was a median of 72 (range 42-120) mm Hg. The peak systolic gradient was more than 50 mm Hg in all but four patients who had symptoms or evidence of left ventricular strain pattern on the electrocardiogram. Three patients underwent balloon dilatation of the left ventricular outflow tract. This was successful in only one patient with isolated supravalve steno- of a close association with the severity of aortic stenosis at presentation. Factors insignificant in relation to survival were the sex of the patient, the presence of syndromes other than Noonan's syndrome, and the presence of aortic regurgitation at presentation. Figure 4 shows the clear separation in time related survival in patients with mild, moderate, and severe aortic stenosis at presentation when adjusted for the presence of the risk factors of age at presentation and Noonan's syndrome. The data in fig 4 indicate that 30 year survival is predicted to be 95 3% for such a patient presenting with mild stenosis, 72-9% for one with moderate stenosis, and 12-0% for one with severe stenosis.
FOLLOW UP Figure 5 shows the distribution of the severity of aortic stenosis in survivors at follow up.
With increasing duration of follow up, there was a reduction in the proportion of patients with moderate stenosis and an increase in the number with no stenosis. The proportion of patients with mild stenosis remained fairly constant at between 60 and 75%. Table 6 shows the current clinical status of all patients.
Discussion
Supravalve aortic stenosis is a rare condition. Only careful follow up of patients over a long period provides an insight into its prognosis. This study comprised the largest group of patients followed from presentation. Most patients were traced and re-examined, and the duration of follow up in survivors allowed predictions of the prognosis into adult life.
INTERVENTION
Although only 47 patients (58%) underwent intervention during the study period, hazard analysis indicated that more patients are likely to undergo intervention the longer the duration of follow up (fig 1) . Patients with other levels of left ventricular outflow tract obstruction have also shown progression with time,1 7 12 but this has not previously been confirmed in a large group of patients with supravalve aortic stenosis. The emergence of increasing severity of aortic stenosis at presentation as a risk factor for intervention, as found in this study, has also been documented in patients with other levels of left ventricular outflow tract obstruction.' 7In general, the presence of multilevel obstruction was closely related to more severe aortic stenosis at presentation, but this was not the case in patients with sporadic supravalve aortic stenosis. Therefore, for the purposes of predicting the likely time intervention, the occurrence of multilevel obstruction in patients with sporadic supravalve aortic stenosis emerged as a significant risk factor, in addition to the information provided by the severity of aortic stenosis at presentation. Noonan's syndrome is a very rare association with supravalve aortic stenosis'3 and the atypical nature of the two patients with this syndrome was confirmed in the requirement for additional interventions. These two patients had additional severe pulmonary valve stenosis and intervention was also combined with relief of this obstruction.
SURVIVAL
Mortality was highest in patients with multilevel obstruction and this indicates the serious nature of this particular condition. Difficulties in the management of patients with multilevel obstruction are reflected in the high postoperative mortality in this group. Hazard analysis predicted that 66% of the study group would be alive after 30 years of follow up, and multivariable analysis indicated that the severity of aortic stenosis at presentation significantly influenced survival. Figure 4 shows the predicted risk of premature death for patients with an identical distribution of risk factors-that is, risk adjusted, in all respects other than the severity of aortic stenosis. Therefore it represents the true effect of the severity of aortic stenosis at presentation on survival. A natural order emerged in terms of premature death with increasing severity of stenosis at presentation, which has also been found in patients with other levels of left ventricular outflow tract obstruction.' 7 The age of the patient at presentation was also shown to modify survival significantly, with younger patients having a poorer outcome. Similar findings have been documented in patients with other levels of left ventricular outflow tract obstruction. ' 7 13 Patients with supravalve stenosis and Noonan's syndrome had a particularly poor survival record, probably because of their associated cardiac conditions. Patients with more than one level of left ventricular outflow tract obstruction are reported to have a worse prognosis than those with a single level of stenosis,14 15 but multivariable analysis has not previously been performed in relation to patients with supravalve aortic stenosis. Perhaps surprisingly, multilevel obstruction did not emerge as a significant risk factor for death. The severity of aortic stenosis at presentation was found to correlate closely with the presence of multilevel obstruction. The significantly higher mortality in patients with multilevel obstruction than in patients with supravalve aortic stenosis alone is thus accounted for by their differences in the severity of aortic stenosis at presentation.
Multilevel obstruction is more common in patients with supravalve aortic stenosis than in those aortic valve stenosis. It occurs in 20-45% of patients with supravalve aortic stenosis,4 16 17 whereas less than 10% of patients with aortic valve stenosis have other levels of obstruction.' 16 18 Diffuse supravalve stenosis is reported in 15-24% of patients,2 17 18 but was lower in the current study. These patients generally have a worse prognosis than those with localised obstruction,2 19 20 The incidence of sporadic supravalve aortic stenosis (22%) was a little lower than in other series,222 possibly because of careful clinical assessment for features of Williams' syndrome and a family history of supravalve aortic stenosis. The relatively older age at presentation in this group may have been because patients with Williams' syndrome or a family history were likely to undergo cardiac examination at a younger age. Reoperation was more common in patients with sporadic supravalve aortic stenosis. This reflects the significantly higher incidence of multilevel obstruction in patients with sporadic supravalve aortic stenosis than in with Williams' syndrome or familial supravalve aortic stenosis and inadequate relief of stenosis at initial operation.
Rubella syndrome is known to be associated with supravalve aortic stenosis,24 and patients with Shone's syndrome have left ventricular outflow obstruction25 which can include supravalve aortic stenosis. The association of Noonan's syndrome with supravalve aortic stenosis is extremely rare. The incidence of these syndromes was low but all had multilevel obstruction. In some ways they were not representative of patients with supravalve aortic stenosis. However, multilevel obstruction did occur in other patients with supravalve aortic stenosis, so it was considered that these patients should not be excluded. Patients with these syndromes presented at a young age, all had other cardiac lesions, and all required surgery for supravalve aortic stenosis. They had the highest mortality of any subgroup, which consisted entirely of early postoperative deaths. Noonan's syndrome emerged as a significant (P < 002) risk factor for intervention and death because of unsuccessful attempts to relieve the coexistent severe right ventricular outflow tract obstruction.
The incidence and distribution of other cardiac lesions was similar to that in other published series.6 '7 The most common lesion was peripheral pulmonary artery stenosis, which occurred in patients with Williams' syndrome and those with the familial types of supravalve aortic stenosis, but was also found in patients with sporadic supravalve aortic stenosis. The higher incidence of aortic arch obstruction in patients with multilevel obstruction emphasises the diffuse nature of left ventricular outflow tract obstruction.
Infective endocarditis occurs in patients with supravalve aortic stenosis'8 but was not encountered in this study. Sudden death did not occur in any patient in this study but it has been reported, in relation to severe supravalve aortic stenosis and obstruction of coronary ostia in patients with mild stenosis.1826
Conclusions
Patients with severe supravalve aortic stenosis present early and undergo intervention at a young age. Patients who present with moderate or mild stenosis fare better, but most will require intervention. Most survivors will have mild stenosis.
